Saturday, August 13, 2011 11:04:54 AM
Date Description
February 1, 2010 Calvin Ross is appointed CFO.
April 1, 2010 Giovanni Luciano is appointed COO
March 22, 2011 Brad Godfrey is appointed CBDO and Director
Brad Godfrey – Chief Business Development Officer/Director Private Investor.
Began Investing in Stocks in 1982 successfully driving my interests to work on Trading Floor of Pacific Stock Exchange and later Wall Street Research in IPO's, Private Placement and Bridge note funding. Currently active as a Private Investor. A Major Shareholder in Hall of Fame Beverages. Appointed Chief Business Development Officer and Director on Board 3/22/2011 to bring Management Changes, changes in Direction and increase valuation for all shareholders. Accomplishments at Hall of Fame Beverages, Inc to be listed in next Annual Report.
Item XIV Beneficial Owners
Set forth are the names, addresses, shareholdings in the company’s stock, of all
persons who beneficially own or control, directly or indirectly, more than 5%
Name: Brad Godfrey
Number of shares held: 730,385,000
I, Calvin Ross, Chief Financial Officer, certify that:
I have reviewed this annual disclosure statement of Hall of Fame Beverages, Inc.;
I, Giovanni Luciano, Chief Operating Officer, certify that:
I have reviewed this annual disclosure statement of Hall of Fame Beverages, Inc.;
I, Brad Godfrey, Chief Business Development Officer/Director, certify that:
I have reviewed this annual disclosure statement of Hall of Fame Beverages, Inc.;
Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and
Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement.
Date: 4/15/11
/s/ Brad Godfrey
Brad Godfrey
CBDO/Director, Hall of Fame Beverages, Inc.
http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=48111
From April 19, 2011 HFBG company filing:
http://www.otcmarkets.com/stock/HFBG/financials
Yeah deffinately seems WindBag JAG could be a puppet.
She stuck her neck out quite far, could be time for a trim.
No way Brad just tucked his tail and went home, no way.
Why the urgency for this letter of condemnation??
Big Trouble coming for HFBG, imo.
WHO IS THE HFBG SECRETARY?
WONDER IF JAG OR THE SECRETARY HAS
ANY CONNECTIONS TO THE OLD REGIME
OTHER THAN WHAT IS STATED??
Pink OTC Markets, Inc.
June 14, 2011
Page 3 of 4
Brad Godfrey, Director and Chief Business Development Officer – number of common and preferred shares held: 730,385,000** and 0*, respectively;
1201 Jones Blvd.
Las Vegas, NV 89146
_________________________________________________________
*As of the date indicated, there are a total of 5,000,000 shares of preferred stock outstanding
representing 50% of the outstanding voting shares at anytime.
** Mr. Godfrey was issued 500,000,000 of these shares in connection with his appointment as an
officer and director; the remaining shares that he owns (230,385,000) were purchased in the open
market at various times prior to his appointment as an officer and director. The later shares although not restricted are “control shares” and can only be publicly sold in accordance with SEC Rule 144.
http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=54036
CHECK OUT PAGE 4: Attorney Letter With Respect To Current Info "Attorney Letter-Fully Executed"
Period Ending March 31, 2011
Filed June 16, 2011
http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=54086
Hope this helps clear any confusion, this wont go unanswered imo
Trouble coming for HFBG and the August 12 2011 letter by JAG is a FLASHING RED LIGHT!!!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM